1. Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study 
Lucas Morin, MS, Davide L. Vetrano, MD, Debora Rizzuto, PhD, Amaia Calderón-Larrañaga, PhD, Johan Fastbom, MD, PhD, Kristina Johnell, PhD 
The American Journal of Medicine 
Volume 130, Issue 8, Pages e9 (August 2017)
DOI: /j.amjmed
Copyright © 2017 The Authors Terms and Conditions

2. Figure
(A) Polypharmacy and (B) number of prescription drugs over the course of the last 12 months of life of older people in Sweden, by living arrangement. Proportions and means are standardized for both sex and age, using the total population as reference. All trends statistically significant (P <.01).
The American Journal of Medicine  , e9DOI: ( /j.amjmed )
Copyright © 2017 The Authors Terms and Conditions

3. Supplementary Figure 1 Study population flowchart.
The American Journal of Medicine  , e9DOI: ( /j.amjmed )
Copyright © 2017 The Authors Terms and Conditions

4. Supplementary Figure 2
Design of drug exposure calculation. Tick marks represent the date of drug dispensing (“start date”). Horizontal lines represent the estimated duration of drug exposure. Arrows represent the end of drug exposure (“end date”).
The American Journal of Medicine  , e9DOI: ( /j.amjmed )
Copyright © 2017 The Authors Terms and Conditions

5. Supplementary Figure 3
Change in the number of nonanalgesic prescription drugs over the course of the last 12 months of life, by living arrangement. Standardized for both sex and age (reference: total population). ATC = Anatomical Therapeutic Chemical classification system.
The American Journal of Medicine  , e9DOI: ( /j.amjmed )
Copyright © 2017 The Authors Terms and Conditions

6. Supplementary Figure 4
Polypharmacy (≥10 Drugs) over the course of the last 12 months of life of older people in Sweden, by illness trajectory and age at time of death.
The American Journal of Medicine  , e9DOI: ( /j.amjmed )
Copyright © 2017 The Authors Terms and Conditions